Rockefeller Capital Management
CLLS

Rockefeller Capital Management’s Cellectis CLLS Stock Holding History

Rockefeller Capital Management’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,083
Closed -$13K – 3788
2021
Q3 		$13K Hold
1,083
– – ﹤0.01% 2761
2021
Q2 		$16K Hold
1,083
– – ﹤0.01% 2571
2021
Q1 		$21K Buy
1,083
+973
+885% +$24.1K ﹤0.01% 2252
2020
Q4 		$2K Sell
110
-29
-21% -$651 ﹤0.01% 2620
2020
Q3 		$2K Buy
+139
New +$2.47K ﹤0.01% 2399

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

Rockefeller Capital Management's CLLS Position: Q4 2021 in Review

Rockefeller Capital Management sold out of Cellectis (CLLS) in Q4 2021, closing a stake of 1,083 shares — an estimated $13K sold.

Rockefeller Capital Management first reported a position in CLLS in Q3 2020 and held it in 5 quarters. The position peaked at $21K in Q1 2021. 57 funds tracked by Wall St. Rank hold CLLS as of Q4 2021.

  • Rockefeller Capital Management reported no remaining Cellectis position as of Q4 2021 after selling out during the quarter.
  • Rockefeller Capital Management sold 1,083 Cellectis shares in Q4 2021, an estimated $13K.
  • Rockefeller Capital Management first reported a position in Cellectis in Q3 2020 and held it in 5 quarters.
  • Rockefeller Capital Management's Cellectis position peaked at $21K in Q1 2021.
  • 57 funds tracked by Wall St. Rank held Cellectis as of Q4 2021.

Based on Rockefeller Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.